| 1 |
31175983 | Human myeloperoxidase (hMPO) is expressed in neurons in the substantia nigra in Parkinson's disease and in the hMPO-α-synuclein-A53T mouse model, correlating with increased nitration and aggregation of α-synuclein and exacerbation of motor impairment. | 2019 Sep |
1 |
| 2 |
24781992 | Effect of MPO/H2O2/NO(-) system on nitric oxide-mediated modification of TTR amyloid and serum TTR in FAP ATTR Val30Met patients. | 2014 Apr 3 |
2 |
| 3 |
23313808 | High density lipoprotein is targeted for oxidation by myeloperoxidase in rheumatoid arthritis. | 2013 Oct |
2 |
| 4 |
22178192 | Site-specific oxidation of apolipoprotein A-I impairs cholesterol export by ABCA1, a key cardioprotective function of HDL. | 2012 Mar |
1 |
| 5 |
22219194 | Myeloperoxidase targets apolipoprotein A-I, the major high density lipoprotein protein, for site-specific oxidation in human atherosclerotic lesions. | 2012 Feb 24 |
1 |
| 6 |
22705369 | Desferrioxamine inhibits protein tyrosine nitration: mechanisms and implications. | 2012 Aug 15 |
1 |
| 7 |
21501700 | Impact of HDL oxidation by the myeloperoxidase system on sterol efflux by the ABCA1 pathway. | 2011 Oct 19 |
1 |
| 8 |
20043647 | Myeloperoxidase: an oxidative pathway for generating dysfunctional high-density lipoprotein. | 2010 Mar 15 |
1 |
| 9 |
20064972 | Oxidation of apolipoprotein A-I by myeloperoxidase impairs the initial interactions with ABCA1 required for signaling and cholesterol export. | 2010 Jul |
2 |
| 10 |
19046613 | Increased nitrotyrosine plasma levels in relation to systemic markers of inflammation and myeloperoxidase in chronic heart failure. | 2009 Jul 10 |
2 |
| 11 |
19060251 | The HDL proteome: a marker--and perhaps mediator--of coronary artery disease. | 2009 Apr |
1 |
| 12 |
19273197 | Role of oxidative and nitrosative stress biomarkers in chronic heart failure. | 2009 Jan 1 |
1 |
| 13 |
19273198 | Role of endothelial cell stress in the pathogenesis of chronic heart failure. | 2009 Jan 1 |
1 |
| 14 |
19628975 | Differences of inflammatory mechanisms in asthma and COPD. | 2009 Sep |
1 |
| 15 |
16476484 | Myeloperoxidase and its contributory role in inflammatory vascular disease. | 2006 Jul |
4 |
| 16 |
16774039 | Pathways for oxidation of high-density lipoprotein in human cardiovascular disease. | 2006 Jun |
2 |
| 17 |
16931637 | Intravascular neutrophil activation due to carbon monoxide poisoning. | 2006 Dec 1 |
1 |
| 18 |
15027099 | Induction of myeloperoxidase and nitrotyrosine formation in a human eosinophilic leukemia cell line, EoL-1. | 2004 Mar-Apr |
1 |
| 19 |
15292228 | Human atherosclerotic intima and blood of patients with established coronary artery disease contain high density lipoprotein damaged by reactive nitrogen species. | 2004 Oct 8 |
4 |
| 20 |
12475975 | Lack of tyrosine nitration by hypochlorous acid in the presence of physiological concentrations of nitrite. Implications for the role of nitryl chloride in tyrosine nitration in vivo. | 2003 Mar 7 |
1 |
| 21 |
12797467 | Myeloperoxidase has directly-opposed effects on nitration reaction--study on myeloperoxidase-deficient patient and myeloperoxidase-knockout mice. | 2003 May |
5 |
| 22 |
12885584 | Oxidative and nitrosative events in asthma. | 2003 Aug 1 |
1 |
| 23 |
12950014 | Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants. | 2003 Sep |
1 |
| 24 |
12361810 | Spatial mapping of pulmonary and vascular nitrotyrosine reveals the pivotal role of myeloperoxidase as a catalyst for tyrosine nitration in inflammatory diseases. | 2002 Oct 1 |
1 |
| 25 |
10922128 | Elevation of nitrotyrosine and nitrate concentrations in cystic fibrosis sputum. | 2000 Aug |
2 |
| 26 |
10956629 | Myeloperoxidase and protein oxidation in cystic fibrosis. | 2000 Sep |
1 |